Alembic Pharmaceuticals LimitedNSE: APLLTD

Press Release Dec 20 2024

· Issued by Alembic Pharmaceuticals Limited

Filed with NSE ·

On 6ix: 6ix.com/news/press-release-dec-20-2024-7

Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated December 20, 2024, titled "Alembic Pharmaceuticals receives USFDA Final Approval for Divalproex Sodium Delayed-Release Capsules USP, 125 mg.".

View Attachment

6ix hasn’t read this filing yet.

Alembic Pharmaceuticals Limited on 6ix

Earlier from Alembic Pharmaceuticals

Later from Alembic Pharmaceuticals

All Alembic Pharmaceuticals news releases